SNAI1 and metabolic dysfunction-associated steatotic liver disease: Hepatocyte-specific ablation of SNAI1 is capable of accelerating insulin-triggered lipogenesis in hepatocytes, aggravating mouse dietary NAFLD, and diminishing insulin resistance (Liu et al. 2018).